## Core Concept
The question pertains to the safety of drugs during pregnancy, focusing on the teratogenic potential and risks associated with drug use in pregnant women. The use of drugs during pregnancy requires careful consideration due to the potential risks to the fetus.

## Why the Correct Answer is Right
is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors are known to have teratogenic effects when used during pregnancy, particularly if used during the second and third trimesters. They can cause fetal renal damage, leading to oligohydramnios, and can also cause hypotension, renal failure, and skull hypoplasia in the fetus. Therefore, ACE inhibitors like are generally contraindicated in pregnancy.

## Why Each Wrong Option is Incorrect
* **Option A:** - This option is not specified, but if it represents a drug that is commonly used or considered safe in pregnancy for certain conditions, it would not be the correct answer because the question seeks a drug not given in pregnancy.
* **Option B:** - Similarly, without specifics, if represents a drug with a different safety profile in pregnancy, it wouldn't be correct if it's not the one clearly contraindicated.
* **Option D:** - Again, without specifics, if is not clearly associated with significant teratogenic effects or contraindications in pregnancy like ACE inhibitors, it wouldn't be the correct choice.

## Clinical Pearl / High-Yield Fact
A key point to remember is that ACE inhibitors and angiotensin receptor blockers (ARBs) are contraindicated in pregnancy due to their association with fetal renal damage and other complications. Pregnant women requiring antihypertensive therapy should be managed with drugs known to be safer during pregnancy, such as methyldopa, labetalol, or nifedipine, under the guidance of a healthcare provider.

## Correct Answer: C.